Crosspoint Capital Strategies, LLC - CHINA BIOLOGIC PRODS INC ownership

CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 106 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2015. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
Crosspoint Capital Strategies, LLC ownership history of CHINA BIOLOGIC PRODS INC
ValueSharesWeighting
Q2 2015$10,000
+42.9%
90
+25.0%
0.00%0.0%
Q1 2015$7,000
+40.0%
72
+4.3%
0.00%
+50.0%
Q4 2014$5,000690.00%
Other shareholders
CHINA BIOLOGIC PRODS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Ariose Capital Management Ltd 88,655$10,149,0009.57%
WARBURG PINCUS LLC 4,087,200$467,903,0008.91%
RUDMAN ERROL M 64,001$7,327,0004.96%
INDUS CAPITAL PARTNERS, LLC 378,518$43,333,0004.22%
OBERWEIS ASSET MANAGEMENT INC/ 90,105$10,315,0002.98%
Ativo Capital Management LLC 85,623$9,802,0002.66%
Sensato Investors LLC 113,296$12,970,0002.31%
Cormorant Asset Management, LP 111,500$12,765,0001.92%
BARING ASSET MANAGEMENT Ltd 128,784$14,743,0001.23%
Visium Asset Management, LP 484,619$55,479,0000.94%
View complete list of CHINA BIOLOGIC PRODS INC shareholders